Literature DB >> 1532812

In vitro and in vivo activation of murine gamma/delta T cells induces the expression of IgA, IgM, and IgG Fc receptors.

M Sandor1, B Houlden, J Bluestone, S M Hedrick, J Weinstock, R G Lynch.   

Abstract

The present studies examined resting and activated murine gamma/delta T lymphocytes, in vitro and in vivo, for surface expression of FcR. Polyclonal gamma/delta TCR+ lymphocytes selectively grown from the spleen and intestine of normal mice did not express FcR when the cells were in a resting state, but when cells were activated with anti-CD3 antibody virtually all of the splenic gamma/delta lymphocytes and a large subpopulation of the intestinal gamma/delta lymphocytes expressed IgA and IgM FcR. This was confirmed by using transgenic mice. Resting gamma/delta TCR+ lymphocytes from the spleen, thymus, lymph node, and blood of gamma/delta TCR transgenic mice did not express FcR for any of the five major classes of Ig H chains. Activation of the gamma/delta TCR+ cells via the CD3/TCR complex induced high levels of IgM and IgA FcR and low levels of IgG FcR. Finally, in hepatic granulomas of schistosome-infected mice, activated gamma/delta TCR+ cells are present and express high levels of IgA and IgM FcR and low levels of IgG FcR. These investigations establish that transition of gamma/delta TCR+ lymphocytes from a resting to an activated state (triggered via the T3Ti TCR complex) is accompanied by the induction of surface membrane receptors specific for Ig H chain isotypes. The activation-linked expression of FcR on gamma/delta TCR+ lymphocytes provides potential mechanisms for coupling the functional activities of gamma/delta T lymphocytes with immune mechanisms that involve Ig molecules, such as antibody-dependent cellular cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532812

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Expression of IgA and IgM Fc receptors on murine T lymphocytes.

Authors:  M Sandor; A Ibraghimov; M G Rosenberg; P Teeraratkul; R G Lynch
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors.

Authors:  R G Lynch
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 3.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  gammadelta T cells are critical for the induction of anterior chamber-associated immune deviation.

Authors:  Y Xu; J A Kapp
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

5.  An alternative Fc gamma-receptor ligand: potential role in T-cell development.

Authors:  M Sandor; J Galon; L Takacs; Y Tatsumi; A L Mueller; C Sautes; R G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Characterization of the Histoplasma capsulatum-induced granuloma.

Authors:  Erika Heninger; Laura H Hogan; Jozsef Karman; Sinarack Macvilay; Bjork Hill; Jon P Woods; Matyas Sandor
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

7.  Role of interleukin-4 in down-regulation of contact sensitivity by gammadelta T cells from tolerized T-cell receptor alpha-/- mice.

Authors:  M Szczepanik; W Ptak; P W Askenase
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

Review 8.  Gammadelta T cells play an essential role in several forms of tolerance.

Authors:  Judith A Kapp; Linda M Kapp; Kyle C McKenna
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 9.  Regeneration of stalled immune responses to transformed and infected cells using γδ T cells.

Authors:  Kenth Gustafsson; John Anderson; Jonathan P H Fisher; Mengyong Yan
Journal:  Drug Discov Today       Date:  2014-03-28       Impact factor: 7.851

Review 10.  Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors.

Authors:  Anil K Chauhan
Journal:  Front Immunol       Date:  2016-06-01       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.